{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:10:15Z","timestamp":1785849015441,"version":"3.56.0"},"reference-count":21,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Myelodysplastic syndromes (<jats:styled-content style=\"fixed-case\">MDS<\/jats:styled-content>), myeloproliferative neoplasms (<jats:styled-content style=\"fixed-case\">MPN<\/jats:styled-content>) and chronic myelomonocytic leukaemia (<jats:styled-content style=\"fixed-case\">CMML<\/jats:styled-content>) can progress to secondary acute myeloid leukaemia (<jats:styled-content style=\"fixed-case\">sAML<\/jats:styled-content>). We compared the outcome of 4214 <jats:styled-content style=\"fixed-case\">sAML<\/jats:styled-content> patients who received allogeneic haematopoietic stem cell transplantation (allo\u2010<jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content>) from an unrelated (62%) or human leucocyte antigen (<jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>)\u2010identical sibling donor (38%) according the underlying disease: <jats:styled-content style=\"fixed-case\">MDS<\/jats:styled-content> (<jats:italic>n<\/jats:italic>\u00a0=\u00a03541), <jats:styled-content style=\"fixed-case\">CMML<\/jats:styled-content> (<jats:italic>n<\/jats:italic>\u00a0=\u00a0251) or <jats:styled-content style=\"fixed-case\">MPN<\/jats:styled-content> (<jats:italic>n<\/jats:italic>\u00a0=\u00a0422). After a median follow up of 46\u00b75\u00a0months, the estimated 3\u2010year progression\u2010free (<jats:styled-content style=\"fixed-case\">PFS<\/jats:styled-content>) and overall survival (<jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>) for the entire group was 36% (34\u201337%) and 41% (40\u201343%), respectively. The cumulative incidence of relapse and non\u2010relapse mortality (<jats:styled-content style=\"fixed-case\">NRM<\/jats:styled-content>) was 37% (35\u201339%) and 27% (26\u201329%), respectively. In a multivariable analysis for <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>, besides age (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001), unrelated donor (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7011), cytomegalovirus \u00b1 constellation (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7007), Karnofsky index\u00a0\u2264\u00a080 (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001), remission status (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001), peripheral blood as stem cell source (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7009), <jats:styled-content style=\"fixed-case\">sAML<\/jats:styled-content> from <jats:styled-content style=\"fixed-case\">MPN<\/jats:styled-content> (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7003) remained a significant factor in comparison to <jats:styled-content style=\"fixed-case\">sAML<\/jats:styled-content> from <jats:styled-content style=\"fixed-case\">MDS<\/jats:styled-content>, while worse outcome of <jats:styled-content style=\"fixed-case\">sAML<\/jats:styled-content> from <jats:styled-content style=\"fixed-case\">CMML<\/jats:styled-content> did not reach statistical significance (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b706). This large registry study demonstrates a major impact of the underlying disease on outcome of <jats:styled-content style=\"fixed-case\">sAML<\/jats:styled-content> after allo\u2010HSCT.<\/jats:p>","DOI":"10.1111\/bjh.15819","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T02:37:25Z","timestamp":1551407845000},"page":"725-732","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia"],"prefix":"10.1111","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2961-4183","authenticated-orcid":false,"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"first","affiliation":[{"name":"University Medical Centre Hamburg\u2010Eppendorf Hamburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diderik\u2010Jan","family":"Eikema","sequence":"additional","affiliation":[{"name":"EBMT Statistical Unit Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"K\u00f6ster","sequence":"additional","affiliation":[{"name":"EBMT Statistical Unit Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Beelen","sequence":"additional","affiliation":[{"name":"University Hospital Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth C.","family":"de Wreede","sequence":"additional","affiliation":[{"name":"Dept of Biomedical Data Science Leiden the Netherlands"},{"name":"DKMS German Bone Marrow Donor Registry Dresden Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Finke","sequence":"additional","affiliation":[{"name":"University of Freiburg Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Koenecke","sequence":"additional","affiliation":[{"name":"Hannover Medical School Hannover Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietger","family":"Niederwieser","sequence":"additional","affiliation":[{"name":"University Hospital Leipzig Leipzig Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum Dresden Dresden Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schoenland","sequence":"additional","affiliation":[{"name":"University Hospital Heidelberg Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Potter","sequence":"additional","affiliation":[{"name":"GKT School of Medicine London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wolschke","sequence":"additional","affiliation":[{"name":"University Medical Centre Hamburg\u2010Eppendorf Hamburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[{"name":"University Hospital Gasthuisberg Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Theobald","sequence":"additional","affiliation":[{"name":"University Medical Centre Mainz Mainz Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kobbe","sequence":"additional","affiliation":[{"name":"University Hospital D\u00fcsseldorf D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"It\u00e4l\u00e4\u2010Remes","sequence":"additional","affiliation":[{"name":"HUCH Comprehensive Cancer Centre Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Wulf","sequence":"additional","affiliation":[{"name":"University Hospital G\u00f6ttingen G\u00f6ttingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kahls","sequence":"additional","affiliation":[{"name":"Medical University of Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Forcade","sequence":"additional","affiliation":[{"name":"CHU Bordeaux Service d'Hematologie Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard","family":"Greinix","sequence":"additional","affiliation":[{"name":"LKH\u2010University Hospital Graz Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Masszi","sequence":"additional","affiliation":[{"name":"Semmelweis University Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Yakoub\u2010Agha","sequence":"additional","affiliation":[{"name":"CHU de Lille LIRIC, INSERM U995 University of Lille Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Chalandon","sequence":"additional","affiliation":[{"name":"Faculty of Medicine of Geneva University Hospital Geneva Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7201-4063","authenticated-orcid":false,"given":"Marie","family":"Robin","sequence":"additional","affiliation":[{"name":"H\u00f4pital St. Louis Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Chronic Malignancies Working Party of the European Society for Blood Marrow Transplantation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1201\/b11826"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000204873"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-714030"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.0890"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420489"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-240135"},{"key":"e_1_2_8_8_1","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.bbmt.2014.05.028","article-title":"Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia: a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"20","author":"Hussein A.A.","year":"2014","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.282"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.3314"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.116715"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyq097"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.7349"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.094284"},{"key":"e_1_2_8_15_1","first-page":"1588","article-title":"Predicting survival and leukemic evolution in patients with myelodysplastic syndrome","volume":"91","author":"Malcovati L.","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2864"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-279794"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02981937"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3343"},{"key":"e_1_2_8_20_1","volume-title":"World Health Organization Classification of Tumours","author":"Swerdlow S.H.","year":"2008"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13576"},{"key":"e_1_2_8_22_1","first-page":"1085","article-title":"Allogeneic bone marrow transplantation for secondary leukemia or myelodysplasia","volume":"84","author":"Witherspoon R.P.","year":"1999","journal-title":"Haematologica"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.15819","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15819","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.15819","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T12:39:05Z","timestamp":1694349545000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.15819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1111\/bjh.15819"],"URL":"https:\/\/doi.org\/10.1111\/bjh.15819","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]},"assertion":[{"value":"2018-10-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}